Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Opioid use may worsen gastric retention Higher prevalence of recent opioid use in the high RGC group Suggests an additive effect on gastric motility No difference in indication or duration of therapy Whether patients used GLP-1 RAs for diabetes or weight loss did not affect risk Duration of therapy was not a significant predictor Interpretation Withholding 7.5 days higher risk of retained gastric contents Fasting 21.3 hours strongest predictor of high RGC These thresholds optimize sensitivity and specificity for detecting risk
What Are GLP-1 Medications and How Do They Work
A limitation of the single-dose trial was the apparent underestimation of semaglutide plasma concentrations with the applied LOCI assay due to a matrix effect
Using tirzepatide improperly can lead to adverse reactions or reduced effectiveness
